Skip to content

A Study on Stress Reduction Effects of Combined Vibration and Music Stimulation

A Confirmatory Trial on Acute Stress Recovery Using Combined Vibration and Music Stimulation with Gradually Slowing Tempo - Tempo-Synchronized Vibro-Music Stimulation for Stress Recovery (TSVMSSR)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058197
Enrollment
36
Registered
2025-06-30
Start date
2021-05-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None (Healthy participants)

Interventions

Variable vibration plus music stimulation Combined vibration and music stimulation synchronized to the participant&#39
s heart rate and gradually slowed to 50 bpm, delivered for approximately 4 minutes via headphones and a handheld vibration device. Music only Participants listened to music only for approximately 4 m

Sponsors

POLA Chemical Industries, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: - Healthy males aged 25 to 49 years - Provided written informed consent after full explanation

Exclusion criteria

Exclusion criteria: History of severe physical illness History of treatments or use of medications that may influence autonomic nervous function Discomfort during hearing tests or when wearing headphones Inability to maintain regular daily routines during the study period

Design outcomes

Primary

MeasureTime frame
Changes in stress indicators (salivary cortisol concentration, VAS, Jikaku-sho Shirabe, and Emotion and Mood Inventory) before and after the intervention under acute stress conditions. Although the study protocol originally specified autonomic nervous system indicators (e.g., HRV) as the primary outcomes, they could not be analyzed due to data quality issues. Therefore, the above indicators were registered and reported as the primary outcomes.

Countries

Japan

Contacts

Public Contacttomomi kato

POLA Chemical Industries, Inc. Frontier Research Center

k-tomo@pola.co.jp045-826-7134

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026